Journal of Neuroinflammation, 2025 · DOI: https://doi.org/10.1186/s12974-025-03351-4 · Published: January 28, 2025
Astrocytes play a helpful role in fixing tissue after injuries to the brain and spinal cord. When these injuries happen, astrocytes start to multiply, but we don't know exactly how this multiplication works inside the cells. This study found that a molecule called heterogeneous nuclear ribonucleoprotein U (Hnrnpu) might be key in controlling how astrocytes multiply and form scars. When the researchers stopped Hnrnpu from working in astrocytes, it made it harder for the astrocytes to form scars, and the mice had trouble recovering their movement and regrowing nerve cells after spinal cord injuries. In human astrocytes, blocking HNRNPU reduced the activity of genes that help astrocytes form scars and regrow nerve cells. These results suggest that changing how astrocytes work by targeting Hnrnpu could be a good way to help people recover from brain and spinal cord injuries.
Astrocytic Hnrnpu is a potential therapeutic target to promote neuronal regeneration after CNS injury.
Endogenous astrocytic Hnrnpu is involved in functional recovery of mice after SCI.
Astrocytic Hnrnpu maintains expression of astrocyte-derived growth-permissive proteins, thereby sustaining axon regeneration and functional recovery.